Which of the following is a primary action of entacapone when used with levodopa for clients with Parkinson's disease?

Inhibits dopamine receptor activity in the CNS

Decreases the side effects of levodopa therapy

Enhances the metabolism of levodopa in peripheral tissues

Inhibits the enzyme that breaks down levodopa